[JAMA] Reduced-Dose Enfortumab Vedotin, Treatment Continuity, and Survival in Urothelial Cancer

roczak Post time Half hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-08-03 18:38

Reward20points

journal：JAMA Oncology

Authors：Ryan D. Chow; Ramy Sedhom; Ronac Mamtani

Published date：2026-1-1

DOI：10.1001/jamaoncol.2025.4566

PDF link：https://jamanetwork.com/journals ... 767385921.68967.pdf

Article link：https://doi.org/10.1001/jamaoncol.2025.4566

Article Source：American Medical Association (AMA)。

Remark：

Reply

All Reply0 Show all posts

roczak Lv.4

Senior Member

[JAMA] Reduced-Dose Enfortumab Vedotin, Treatment Continuity, and Survival in Urothelial Cancer Copy